The Global Lidocaine Ointment Market Is Witnessing High Growth Owing To the High Incidence of Surgeries in the World
![]() |
| Lidocaine Ointment |
Lidocaine Ointment Market, by Formulation (Internal Use and Topical
Use), by Age Group (Children and Adults), by Application (Insect Bite, Sun
Burn, Minor Cut, Mouth Sore, and Others), by Distribution Channel (Hospital
Pharmacies, Retail Pharmacies, and Online Pharmacies), by Region (North
America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share,
Outlook, and Opportunity Analysis, 2022 - 2030.
Market Overview:
Lidocaine Ointment is a type of medication that helps to relieve
the pain associated with many skin conditions, including bug bites, rashes,
minor burns, abrasions, cuts, cold sores, hemorrhoids, and more. It works by
preventing pain signals from reaching the brain, thus relieving the symptoms of
these conditions. The medication is a member of a group of drugs called local
anesthetics, which can help to prevent pain during procedures. In some cases,
lidocaine can even be used to reduce the pain associated with certain X-ray
pictures and dental impressions. This medicine can cause serious side effects
if it is not used properly or at the right dose. Use this medication for only
the medical condition for which it was prescribed. Overuse or misuse of this
drug may cause severe side effects or death.
Competitive Landscape:
Major players operating in the global Lidocaine
Ointment Market include
SEPTODONT, Inc., Zuche Pharmaceuticals Private Limited., Quagen
Pharmaceuticals, Zydus Healthcare Limited., Sandoz AG, Aspen Pharmacare
Australia Pty Ltd., Hi-Tech Pharmaceuticals, Liberty Pharmaceuticals, Inc.,
Ascend Laboratories LLC, Alembic Pharmaceuticals Limited, Amneal
Pharmaceuticals LLC., Novocol Pharma, ASTRAZENECA CANADA INC., Neon
Laboratories Ltd., CENTURA PHARMACEUTICALS INC., Taro Pharmaceutical Industries
Ltd., Teligent Inc., and Glenmark Pharmaceuticals U.S. Inc.
Key Market Drivers:
The increasing incidence of surgeries in the
world is expected to augment the growth of the global Lidocaine Ointment Market. For instance, according to the National
Institutes of Health (NIH), around 234 million surgeries take place annually
worldwide. Lidocaine ointment should be applied to clean, dry, intact skin, as
directed by the doctor. Do not apply the patch or topical system to an open
wound, skin that is irritated or red, or any area of the body where patients
are sensitive to oxidizing chemicals such as chlorine or hydrogen peroxide
(found in some cleaning supplies and hair dyes). If patients need to use this
medicine for a long time, do not increase the amount of it they use. Overdosage
can lead to serious health problems, such as seizures or methemoglobinemia (a
condition where the red blood cells do not deliver enough oxygen). Moreover,
advancements related to surgical anesthetics are estimated to enhance the
growth of the global lidocaine ointment market.
Covid-19 Impact Analysis
During the COVID-19 pandemic, there have been
several developments in the global lidocaine ointment market. For instance,
according to the Journal of Cardiovascular Development and Disease,
dysrhythmias resulting due to SARS-CoV-2 infection exhibit high-grade
ventricular tachycardia, atrial fibrillation, and atrioventricular block. This
boosted the growth of the market.
Key Takeaways
· North America is expected to dominate the
growth of the global Lidocaine Ointment
Market, owing to the increasing incidence of non-surgical procedures. For
instance, according to the American Society for Aesthetic Plastic Surgery, in
2022, the U.S. witnessed a 44% increase in non-surgical procedures.
· The Asia Pacific is estimated to witness high
growth in the global Lidocaine Ointment
Market, owing to the increasing developments by key companies in the
region. For instance, in April 2022, Alembic Pharmaceuticals Limited and Aleor
Dermaceuticals Limited received approval from the Food and Drug Administration
(USFDA) for their Lidocaine and Prilocaine Cream.

Comments
Post a Comment